Alpha Teknova Inc (TKNO) - Forward Price-to-Revenue Multiple

teknova.com (TKNO) - corporate logo

The impeccable quality of Alpha Teknova, Inc. (TKNO) reagents has established a solid foundation for expansion, as confirmed by the forward price-to-sales ratio on GURU.Markets. Stable sales are driven by the integration of the brand's chemistry into the technical processes of pharma behemoths, although a narrow specialization in gene therapy ties profits to biotech budgets. The current value of 9.70 reflects the metric's balance between market value and revenue expectations.

TKNO teknova.com: Forward Price-to-Revenue Multiple in the range 07/04/2022 - 11/13/2026

Teknova Inc - analytical breakdowns and key metrics (TKNO)

- market price and analyst price targets:
Price Chart Teknova|TKNO - Fair Value Consensus
- market capitalization indicators:
Market Valuation Teknova Inc|TKNO - Enterprise Value
- business book valuation details:
Net Assets per Single Share Teknova|TKNO - Company Net Assets|Market Capitalization to Book Value Ratio teknova.com|TKNO - Company Assets
- issuer credit burden and liquidity indicators:
Debt to Equity Alpha Teknova, Inc.|TKNO - Long-Term Debt to Capital Ratio|Short-Term Debt to Equity Ratio Alpha Teknova, Inc.|TKNO - Company Cumulative Indebtedness|Debt to Book Capitalization Ratio Teknova Inc|TKNO - Long-Term Debt Volume|Company Short-Term Debts Teknova|Quick Liquidity teknova.com
- business earnings and investment ratios data:
TKNO - Company Net Income|Expected Profit Alpha Teknova, Inc.|TKNO - Market Cap to Net Income|Forward P/E Multiple Alpha Teknova Inc|TKNO - Growth-Adjusted Payback Ratio|EV/EBITDA Multiple Teknova Inc|TKNO - Operating profit EBITDA|Net earnings per share for the last 12 months Teknova|TKNO - Earnings per share for the trailing year|Year-over-year net earnings per share growth for the last 12 months teknova.com|TKNO - Net earnings per one share growth for the current year|Earnings growth forecast for next year Alpha Teknova, Inc.
- sales and revenue data:
TKNO - Company Total Revenue|Company Projected Revenue Teknova|TKNO - P/S Multiple|Price-to-Projected Revenue Ratio Teknova Inc
General company analysis:TKNO (Teknova)
Original product of teknova.com

Alpha Teknova, Inc. (TKNO) is developing high-tech production of biotechnological reagents in California, leveraging automation and the stability of purification systems. By analyzing forward EV/Revenue on GURU.Markets, an investor tracks the ratio of the business's market value to expected sales, which offsets quarterly volatility and allows for an assessment of the company's fundamental value through the lens of future cash flows and revaluation risks.

Analysis of competing companies

Price-to-Projected Revenue Ratio Intuitive ISRG|Forward Price to Sales DHR|BDX: Forward Price-to-Revenue Multiple|STE - Forward P/S Multiple|West Pharmaceutical Services (WST) - Price-to-Projected Revenue Ratio|Forward Price-to-Revenue Multiple baxter.com|MASI (Masimo) - Forward P/S Multiple|Market Cap to Future Revenue Ratio Stevanato Group SpA STVN|Price-to-Projected Revenue Ratio Teleflex Inc (TFX)|Merit Medical Corp - Market Cap to Projected Revenue|Envista Holdings - Forward Price-to-Revenue Multiple|Price to Expected Revenue Ratio ICUI (icumed.com)|XRAY - Price-to-Projected Revenue Ratio|Market Cap to Expected Sales Ratio LeMaitre Vascular Inc LMAT|ATRC: Forward P/S Multiple|STAAR Surgical Co (STAA) - Forward P/S Multiple|Price-to-Projected Revenue Ratio ChromaDex Corporation|Price-to-Projected Revenue Ratio ZIMV|Price-to-Projected Revenue Ratio AngioDynamics (ANGO)|CERS: Future Price to Revenue|Forward P/S Multiple MGRM (Monogram Technologies Inc)|Forward Price to Sales STSS|InfuSystem Inc - Forward P/S Multiple|UTMD - Forward P/S Multiple|KRMD (korumedical.com) - Forward Price-to-Revenue Multiple|Nyxoah SA - Forward Price to Sales|Forward Price-to-Revenue Multiple MBOT|PDEX (Pro-Dex Inc.) - Price to Expected Revenue Ratio|Forward P/S Multiple ZTEK|ELUT - Market Cap to Future Revenue Ratio|Price-to-Projected Revenue Ratio Milestone Scientific Inc. MLSS|Forward P/S Multiple NEXGEL Inc. NXGL|RVP - Price-to-Projected Revenue Ratio|HBIO (harvardbioscience.com) - Market Cap to Projected Revenue|Femasys Inc. (FEMY) - Price-to-Projected Revenue Ratio|Market Cap to Future Revenue Ratio Meihua Medical Technologies Co., Ltd. (MHUA)|Forward Price-to-Revenue Multiple POAI|Price-to-Projected Revenue Ratio CJMB|Forward P/S Multiple ATRI|Forward P/S Multiple NeuroMetrix Corporation (NURO)